Pharmaceutical Followers
44 Pages Posted: 11 Oct 2013 Last revised: 6 May 2023
There are 2 versions of this paper
Pharmaceutical Followers
Date Written: October 2013
Abstract
We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and ``me-too'' drugs each increased consumer welfare more than $100 million in 2010, holding insurance premiums constant. However, insurance payments in 2010 fell by nearly $1 billion due to generics and rose by over $7 billion due to me-too antiulcer drugs.
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Prescription Drugs, Medical Care, and Health Outcomes: A Model of Elderly Health Dynamics
By Zhou Yang, Donna B. Gilleskie, ...
-
Integrated Insurance Design in the Presence of Multiple Medical Technologies
By Dana P. Goldman and Tomas Philipson
-
Is Drug Coverage a Free Lunch? Cross-Price Elasticities and the Design of Prescription Drug Benefits
By Martin Gaynor, Jian Li, ...
-
Is Drug Coverage a Free Lunch? Cross-Price Elasticities and the Design of Prescription Drug Benefits
By Martin Gaynor, Jian Li, ...
-
By Amitabh Chandra, Jonathan Gruber, ...
-
By Avi Dor and William E. Encinosa
-
By William H. Crown, Ernst R. Berndt, ...
-
Prescription Drug Coverage and Elderly Medicare Spending
By Baoping Shang and Dana P. Goldman